Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC M&A Activity 2021

Feb 9, 2021

5250_rns_2021-02-09_1f294327-b662-45d1-b060-0289c5bedcaa.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC Amendment

Ap19

FORM 8.3 Amendment to Purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 03 February 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,322,722 1.80% 610,191 0.47%
(2) Derivatives (other than options):
273,127 0.21% 441,267 0.34%
(3) Options and agreements to
purchase/sell: 6,000 0.00% 6,000 0.00%
TOTAL:
2,601,849 2.02% 1,057,458 0.82%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 2 207.1500 USD
Purchase 4 210.9200 USD
Purchase 14 206.5800 USD
Purchase 20 208.4000 USD
Purchase 42 205.9966 USD
Purchase 60 206.3233 USD
Purchase 76 206.0382 USD
Purchase 98 206.0642 USD
Purchase 100 206.0900 USD
Purchase 100 207.1900 USD
Purchase 100 205.7000 USD
Purchase 102 206.0623 USD
Purchase 112 205.8525 USD
Purchase 121 207.3761 USD
Purchase 126 205.9166 USD
Purchase 202 208.2825 USD
Purchase 284 205.9912 USD
Purchase 300 208.8300 USD
Purchase 400 206.1200 USD
Purchase 1,001 207.7268 USD
Purchase 1,213 208.2098 USD
Purchase 1,287 206.2268 USD
Purchase 2,970 206.4256 USD
Purchase 3,636 208.4574 USD
Purchase 5,202 208.0771 USD
Purchase 6,203 207.0779 USD
Purchase 6,506 206.2044 USD
Purchase 11,688 206.2000 USD
Purchase 35,600 208.8150 USD
Sale 1 208.0400 USD
Sale 1 207.8750 USD
Sale 1 206.8400 USD
Sale 2 208.0350 USD
Sale 2 207.9950 USD
Sale 3 207.2750 USD
Sale 8 209.8500 USD
Sale 13 207.3184 USD
Sale 14 206.1000 USD
Sale 22 208.4800 USD
Sale 150 207.8800 USD
Sale 154 208.1020 USD
Sale 184 208.1882 USD
Sale 200 208.2850 USD
Sale 204 208.2858 USD
Sale 280 208.0771 USD
Sale 293 208.1039 USD
Sale 300 208.8300 USD
Sale 357 206.5615 USD
Sale 375 208.0373 USD
Sale 379 208.0396 USD
Sale 400 208.0425 USD
Sale 400 206.1200 USD
Sale 1,148 208.3656 USD
Sale 1,266 206.2071 USD
Sale 1,921 208.0792 USD
Sale 2,541 206.2074 USD
Sale 3,044 206.8156 USD
Sale 3,515 208.4358 USD
Sale 3,620 206.3916 USD
Sale 7,251 207.1555 USD
Sale 12,236 206.2000 USD
Sale 35,600 208.8150 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 9 Feb 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005518/en/

BARCLAYS PLC